HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Insilico Medicine Releases Pandomics, AI-powered Platform for Novel Therapeutic Target Discovery
The company started working on an engine for target identification back in 2014. Since then, the technology has been validated through several successful partnering initiatives with pharmaceutical companies and research organizations as well as through Insilico Medicine's own internal drug development programs.
HART KD a Highly Accurate, Artificial Intelligence-driven Blood Test for Kawasaki Disease
The company used their long-standing, certified laboratory partner, Myriad RBM, to conduct protein measurements on blood samples collected from children with Kawasaki disease and is developing commercial options for offering HART KD for children suspected of Kawasaki disease.
Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology...
Agendia notes this study confirms findings from the STO-3 Trial, previously published in 2017 in JAMA Oncology, and continues to show that the use of MammaPrint to stratify patient populations could help prevent the overtreatment of breast cancer patients.
BioPorto Plans Initial Clinical Evaluation of gRAD-based Test for Rapid Detection of COVID-19 Virus
BioPorto notes it is designed to provide a qualitative result in under 10 minutes from a minimally invasive sample, and to be easily administered at the point of care, the test could provide a much-needed solution to help improve access to viral testing.
Immunexpress Presents Data on Clinical Validation of SeptiCyte® RAPID for Diagnosing Sepsis at e-ISICEM
Immunexpress notes the first poster, titled "Clinical Performance of a Rapid Sepsis Test on a Near-Patient Molecular Testing Platform," details the clinical validation of SeptiCyte® RAPID. The study compares Immunexpress' rapid version of the SeptiCyte® assay on the Biocartis Idylla™ platform to SeptiCyte® LAB in patients located in the U.S. and Europe.
Progentec Diagnostics Announces Launch of Novel Test That Anticipates Onset of Lupus-Related Flares
The aiSLE™ DX Flare Risk Index uses a set of blood-based biomarkers that are measurably altered before the onset of flare symptoms in patients with systemic lupus erythematosus.
Cernostics and Deciphex Strategic Collaboration – To Evaluate the Use of AI-Driven Image Analysis Tools and Technology to Improve Upon Early Detection of Cancer...
This collaboration combines the technological resources of both companies and will apply these to one of the world's largest cohorts of Barrett's esophagus patients with clinical outcome data, including patients who progressed to esophageal cancer.
Aegea Biotechnologies Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition
Aegea Biotechnologies notes XPRIZE is renowned for its worldwide competitions to solve humanity's most important challenges. The $5 million, XPRIZE Rapid COVID Testing competition was launched this summer to accelerate the development of high-quality COVID-19 testing that is affordable, easy to use, and that has a fast turnaround time.
ARUP Laboratories Now Offers COVID-19 Saliva Testing – Available with Preapproval to ARUP Clients Nationwide
ARUP Laboratories will perform the test only on saliva specimens collected using an ARUP collection kit with a healthcare provider present. ARUP validated the test using its kit on high-throughput instruments, and cannot perform it on other saliva specimens without jeopardizing quick turnaround times, said Adam Barker, Ph.D., director of ARUP's new COVID-19 Rapid Response Lab.